34 DAFTAR PUSTAKA Alberti, K.G.M.M., Zimmet, P., Shaw, J., 2006. Metabolic Syndrome - A new world wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 23 : 469 480. Anggara, F.H.D., Prayitno, N., 2013. Faktor Faktor yang berhubungan dengan Tekanan darah di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012. Jurnal Ilmiah Kesehatan, 5(1) : 20 25. Armstrong, A.W., Lin, S.W., Chambers, C.J., Sockolov, M.E., Chin, D.L., 2011. Psoriasis and Hypertension Severity : Results from a Case-Control Study. PLoS ONE, 6(3) : e18227. Armstrong, E.P., Malone, D.C., 2003. The Impact of Non-steroidal Antiinflammatory Drugs on Blood Pressure, with an Emphasis on Newer Agents. Clin Ther., 25 : 1 18. Barnetson, R & White, A., 2006. Working in the tropics. In : Tyring, S.K., et al., eds. Tropical Dermatology. USA: Elsevier Inc, 22 26. Bowcock, A.M., 2005. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology. Immunologic Research, 32: 45-46. Canadian Hypertension Education Program, 2013. Accurate Measurement of Blood Pressure : Table 1. Recommended Technique for Measuring Blood Pressure. Hypertension Canada. Available From : http://www.hypertension.ca/iframes/cheptables/table1.html?ml=1&ml=1&ml= 1 [Accessed 22 Mei 2013] Cohen, A.D., Weitman, D., Dreiher, J., 2010. Psoriasis and Hypertension : A Case-Control Study. Acta Derm Venereol, 90: 23 26.
35 Cohen, A.D., Sherf, M., Vidavsky, L., Vardy, D.A., Shapiro, J., Meyerovitch, J., 2008. Association between Psoriasis and the Metabolic Syndrome. Dermatology, 216(2) : 152 155. Department of Health and Human Services. 2003. The Seventh Report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The National Heart, Lung, and Blood Institute, The Executive Committee. Djuanda, A., 2010. Dermatosis Eritroskuamosa. Dalam : Djuanda, A., ed. Ilmu Penyakit Kulit dan Kelamin. 6 th ed. Jakarta: Balai Penerbit FK UI, 189-195. Fisher, N.D.L. & Williams, G.H., 2005. Hypertensive Vascular Disease. In : Kasper, D.L., et al., eds. Harrison s Principle of Internal Medicine. 16 th ed. USA: McGraw-Hill, 1466. Ghazali, M.V., Sastromihardjo, S., Soedjarwo, S.R., Soelaryo, T., Pramulyo, H.S., 2008. Studi cross-sectional. Dalam : Sastroasmoro, S., Ismael, S., et al., eds. Dasar-dasar Metodologi Penelitian Klinis. Jakarta : Sagung Seto, 112-126. Ghiasi, M., Nouri, M., Abbasi, A., Hatami, P., Abbasi, M.A., Nourijelyani, K., 2011. Psoriasis and increased prevalence of hypertension and diabetes mellitus. Indian J Dermatol, 56 : 533 536. Griffiths, C.E. & Barker, J.N., 2007. Pathogenesis and Clinical Features of Psoriasis. Lancet, 370 : 263 271. Gudjonsson, J.E. & Elder, J.T., 2008. Psoriasis. In : Wolff K., et al., eds. Fitzpatrick's Dermatology in General Medicine. 7 th ed. USA: The McGraw-Hill Companies, 169-193.
36 Hayashi, R., Yamashita, N., Matsui, S., Fujita, T., Araya, J., Sassa, K., Arai, N., Yoshida, Y., Kashii, T., Maruyama, M., Sugiyama, E., Kobayashi, M., 2000. Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur Respir J, 16 : 452 458. Huerta, C., Rivero, E., Rodriguez, L.A.G., 2007. Incidence and Risk Factors for Psoriasis in the General Population. Arch Dermatol, 143(12) : 1559-1565. Huskic, J., Mulabegovic, N., Alendar, F., Ostojic, L., Ostojic, Z., Simic, D., Milicevic, R., Naletilic, M., 2008. Serum and Tissue Angiotensin Converting Enzyme in Patients with Psoriasis. Coll Antropol, 32 (4) : 1215-1219. Icen, M., Crowson, C.S., McEvoy, M.T., Dann, F.J., et al., 2009. Trends in incidence of adult-onset psoriasis over three decades : a population based study. J Am Acad Dermatol, 60(3) : 394-401. James, W.D., Berger, T.G., Elston, D.M., 2006. Andrew s Diseases of the Skin. 10 th ed. Philadelphia : Elsevier Inc, 193 201. Kaplan, N.M., 2006. Kaplan s Clinical Hypertension. 9 th ed. Philadelphia : Lippincott Williams & Wilkins, 103 104. Kranzhofer, R., Schmidt, J., Pfeiffer, C.A.H., Hagl, S., Libby, P. Kubler, W., 1999. Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells. Available From: http://atvb.ahajournals.org/content/19/7/1623.long [Accessed 22 Mei 2013]. Kurd, S.H., Troxel, A.B., Crits-Christoph, P., Gelfand, J.M., 2010. The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis. Arch Dermatol, 146(8) : 891 895.
37 Lee, C.T., Williams, G.H., Lilly, L.S., 2011. Hypertension. In : Lilly, L.S., ed. Pathophysiology of Heart Disease a collaborative project of medical students and faculty. 5 th ed. Philadelphia : Lippincott Williams & Wilkins, 301 323. Madanagobalane, S., Anandan, S., 2012. Prevalence of Metabolic Syndrome in South Indian Patients with Psoriasis Vulgaris and the Relation Between Disease Severity and Metabolic Syndrome : A Hospital-Based Case- Control Study. Indian J Dermatol, 57 : 353 357. Mukhtar, Z., 2011. Desain Penelitian. Dalam : Mukhtar, Z., ed. Desain Penelitian Klinis dan Statistika Kedokteran. 1 st ed. Medan : USU press, 72 75. Murad, A & Tobin, A.M., 2012. Cardiovascular Disease in Inflammatory Disorders Psoriasis and Psoriatic Arthritis. Available From : www.intechopen.com/download/pdf/32661. [Accessed 2 December 2013] Naldi, L., Chatenoud, L., Belloni, A., Peserico, A., et al., 2005. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis : results from an Italian case-control study. J Invest Dermatol, 125: 61-67. National Heart, Lung, and Blood Institute, 2010. What is Hypotension?. Available From : http://www.nhlbi.nih.gov/health/health-topics/topics/hyp/ [Accessed 2 December 2013] Niehof, M. & Borlak, J., 2011. HNFalpha Dysfunction as a Molecular Rational for Cyclosporine Induced Hypertension. PLoS ONE, 6(1) : e16319. Nestle, F.O., Kaplan, D.H., Barker, J., 2009. Mechanisms of disease Psoriasis. N Eng J Med, 361: 469 509.
38 Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figueiredo, A., Quintanilha, A., Teixeira, F., 2001. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clinica Chimica Acta, 303: 33-29. Schön, M.P., Boehncke, W.H., 2005. Medical Progress Psoriasis. N Eng J Med, 352: 1899 1912. Sherwood, L. 2010. Human Physiology from cells to systems. 7 th ed. USA : Cengage Learning, 350 351. Siregar, R.S., 2000. Psoriasis. Dalam : Harahap, W., ed. Ilmu Penyakit Kulit. Jakarta : Hipokrates, 116 126. Sowers, J.R., 2002. Hypertension, Angiotensin II, and Oxidative Stress. N Engl J Med, 346: 1999 2001. Strom, J.B., Libby, P., 2011. Atherosclerosis. In : Lilly, L.S., ed. Pathophysiology of Heart Disease a collaborative project of medical students and faculty. 5 th ed. Philadelphia : Lippincott Williams & Wilkins, 113-134. Sugiharto, A. 2007. Faktor-Faktor risiko Hipertensi grade II pada masyarakat (Studi Kasus di Kabupaten Karanganyar). Tesis. Semarang : Program Studi Epidemiologi Program Pasca Sarjana Universitas Diponegoro. Tortora, G.J., Derrickson, B., 2012. The Cardiovascular System: Blood Vessels and Hemodynamics. In: Roesch, B., et al., eds. Principles of Anatomy and Physiology. 13 th ed. USA: John Wiley & Sons, 817. Tozawa, M., Oshiro, S., Iseki, C., Sesoko, S., Higashiuesato, Y., Tana, T., Ikemiya,Y., Iseki, K., Fukiyama, K., 2001. Family History of Hypertension and Blood Pressure in Screened Cohort. Hypertens Res, 24 : 93 98.
39 Wakkee, M., Thio, H.B., Prens, E.P., Sijbrands, E.J.G., Neumann, H.A.M., 2007. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis, 190: 1-9. Wandeler, G., Paccaud, F., Vollenweider, P., Waeber, G., Mooser, V., Bochud, M., 2010. Strength of Family History in Predicting Levels of Blood Pressure, Plasma Glucose and Cholesterol. Public Health Genomics, 13 : 143 154.